July 15th, 2019 – An Australia-based, worldwide leader in influenza prevention announced it is the first to ship seasonal influenza vaccines to customers in the United States for the 2019-2020 influenza season.   

Seqirus said in a July 15, 2019 press release that it ‘expects to distribute over 50 million doses to the U.S. market this year, with the majority of doses coming from its adjuvanted and cell-based technology platforms.’ 

Read more: Seqirus ShipsInfluenza Vaccine

The Centers for Disease Control and Prevention (CDC) is expecting a 3 to 10 month nationwide shortage of APLISOL®, a product of Par Pharmaceuticals. APLISOL® is one of two purified-protein derivative (PPD) tuberculin antigens that are licensed by the United States Food and Drug Administration (FDA) for use in performing tuberculin skin tests. The manufacturer notified CDC that they anticipate a supply interruption of APLISOL® 5 mL (50 tests) beginning in June 2019, followed by a supply interruption of APLISOL® 1 mL (10 tests) in November 2019. The expected shortage of APLISOL® 1 mL (10 tests) could occur before November 2019, if demand increases before then. The 3-10 month timeframe for the nationwide shortage is the manufacturer’s current estimate and is subject to change. Read More...

VANCOUVER, Wash. (AP) — The number of confirmed measles cases near Portland grew to 31 on Friday — an outbreak boosted by lower-than-normal vaccination rates in what has been called an anti-vaccination U.S. “hot spot.” Read more. . 

Federal safety and health investigators have cited Altamont Ambulance Service Inc. in Fairview Heights, Ill., for workplace safety and health violations and fined the company $290,100.

The federal Occupational Safety and Health Administration said Altamont failed to follow specific guidelines to protect emergency healthcare workers from exposure to bloodborne pathogens and other hazards while providing patient care.

OSHA issued five willful, 16 serious and three other-than-serious safety and health violations to the emergency medical service provider. The agency opened inspections in January 2016, after receiving a complaint alleging violations of OSHA’s bloodborne pathogen exposure and various other health and safety standards.

Read more...
View the OSHA citations